Bafna Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr Navin Kumar as an Additional Director (Non- Executive Independent Director) of the company w.e.f. Jun 23, 2025.
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bafna Pharmaceuticals has appointed Mr. Navin Kumar (DIN: 08778662) as an Additional Director (Non-Executive Independent Director) effective June 23, 2025, for a one-year term. The appointment was made by the Board based on the recommendation of the Nomination and Remuneration Committee and is subject to shareholder approval. Mr. Kumar is a Chartered Accountant with over 13 years of experience in corporate finance, taxation, auditing, and regulatory compliance. The company confirmed he is not debarred from holding directorship by SEBI or any other authority and has no relationships with existing directors.
This is a routine independent director addition that strengthens the board's financial and compliance expertise. For shareholders, the appointment requires approval at a general meeting, but it is unlikely to materially affect the stock price.